| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/17/2002 | US6451352 Adminsitering sea water as antiinflammatory agent to mucous membranes of the respiratory tract |
| 09/17/2002 | US6451351 Method for preparing gel with calcium salts of organic acids |
| 09/17/2002 | US6451350 Coating with aqueous ethyl cellulose and lipophilic plasticizing diester; drying |
| 09/17/2002 | US6451349 Basification of zinc-insulin dissolved in acid; forming microparticles; administering to lungs |
| 09/17/2002 | US6451348 Method of manufacturing porous matrix-type controlled release systems using emulsion technique |
| 09/17/2002 | US6451347 Complexing oxidized or deamidated human growth hormone with metal; precipitation, isolation |
| 09/17/2002 | US6451346 Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents |
| 09/17/2002 | US6451345 Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration |
| 09/17/2002 | US6451344 Sugar coated tablets |
| 09/17/2002 | US6451343 A-(methoximino)-a-(1-azabicyclo(2.2.2)oct-3-yl)acetonitrile hydrochloride amyloid precursor protein intensifier |
| 09/17/2002 | US6451342 Core formulation comprised of troglitazone and a biguanide |
| 09/17/2002 | US6451341 Time release formulation of vitamins, minerals and other beneficial supplements |
| 09/17/2002 | US6451339 Drug delivery |
| 09/17/2002 | US6451338 Controlling particle size; foring liposomes, freeze drying, rehydration |
| 09/17/2002 | US6451335 Formulations and methods for providing prolonged local anesthesia |
| 09/17/2002 | US6451334 Pulse administering of a c1-c4 substituted and/or phenyl substituted carboxylic acid and salts and a carrier or diluent to stimulate cells in treating blood disorders, e.g. sickle cell anemia, thalassemia, blood loss etc. |
| 09/17/2002 | US6451327 Granulated anionic, nonionic, and/or amphoteric surfactants and binder in nonaqueous base; sensistivity; massaged feel |
| 09/17/2002 | US6451325 Vaccines; oil in water emulsion and detergent; lipophilic muramyl dipeptide immunostimulant; free of ethylene oxide-propylene oxide block copolymer |
| 09/17/2002 | US6451302 Parenteral water-miscible non-intensely colored injectable composition of non-steroidal anti-inflammatory drugs |
| 09/17/2002 | US6451297 Powders having a granulometry of 30 to 500 microns, applicable directly to the wet hair and/or the body and surfactants |
| 09/17/2002 | US6451295 Siliconized polyamide formulated with at least one silicone material and at least one non-silicone emollient; clear products with improved structural stability and integrity |
| 09/17/2002 | US6451290 Products and methods for the remineralization and prevention of demineralization of teeth |
| 09/17/2002 | US6451288 Method of treating lung diseases with uridine 5′-diphosphate and analogs thereof |
| 09/17/2002 | US6451287 An amphiphilic fluorinated block copolymer having at least one lyophobic block and at least one lyophilic block, wherein each of said blocks are formed from monomers |
| 09/17/2002 | US6451286 Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds |
| 09/17/2002 | US6451285 Mixture of drug, propellant and solvent |
| 09/17/2002 | US6451256 Recombinant viruses in frozen or liquid form, in which infectious viruses are preserved in an aqueous solution. the recombinant virus suspension comprises an aqueous sucrose solution at a concentration for gene therapy. |
| 09/17/2002 | US6451122 Dextrose in powder form and a process for the preparation thereof |
| 09/17/2002 | US6450991 Delivery devices and their use |
| 09/17/2002 | CA2365412C Orally administrable solid ribavirin dosage forms and process for making them |
| 09/17/2002 | CA2232635C Intravaginal rings with insertable drug-containing core |
| 09/17/2002 | CA2223417C Method for the manufacture of minimal volume capsules containing biological material |
| 09/17/2002 | CA2222304C Pharmaceutical amiodarone composition for parenteral delivery |
| 09/17/2002 | CA2184594C Antitussive composition containing an antitussive and benzydamine |
| 09/17/2002 | CA2182576C Bilayer preparations |
| 09/17/2002 | CA2072420C Storage of materials |
| 09/17/2002 | CA2020431C Aqueous liquid eyedrop composition |
| 09/17/2002 | CA2019095C Bio-adhesive composition |
| 09/16/2002 | CA2376843A1 Inhomogeneous silicas as carrier material |
| 09/12/2002 | WO2002070594A2 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 09/12/2002 | WO2002070526A1 Organometallic building materials and method for producing the same |
| 09/12/2002 | WO2002070524A2 N-but-3-enyl norbuprenorphine and its use as analgesic |
| 09/12/2002 | WO2002070470A2 Benzophenones as inhibitors of reverse transcriptase |
| 09/12/2002 | WO2002070438A2 Compositions for delivering bisphosphonates |
| 09/12/2002 | WO2002070047A1 Non-constant pressure infusion pump |
| 09/12/2002 | WO2002070021A1 Gastric delivery of antineoplastic agents and methods of treatment via inhibition of cancer cell using them |
| 09/12/2002 | WO2002070014A1 Compositions comprising an o/w emulsion containing conjugated linoleic acid |
| 09/12/2002 | WO2002070013A1 Utilization of spray-dried powder containing sugar alcohol |
| 09/12/2002 | WO2002069999A1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 09/12/2002 | WO2002069996A1 Induced metaplastic mucous cell apoptosis |
| 09/12/2002 | WO2002069993A1 Pharmaceutical composition made of cannabis extracts |
| 09/12/2002 | WO2002069983A1 Amphotericin b aqueous composition |
| 09/12/2002 | WO2002069978A1 Progestin co-micronized with a surfactant, pharmaceutical composition comprising same, methods for making same and uses thereof |
| 09/12/2002 | WO2002069969A1 A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate |
| 09/12/2002 | WO2002069967A1 Percutaneous absorption compositions |
| 09/12/2002 | WO2002069966A1 Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction |
| 09/12/2002 | WO2002069962A1 Compositions and preparations of silymarin complex with the improved bioavailability |
| 09/12/2002 | WO2002069957A1 Fenofibrate-containing composition |
| 09/12/2002 | WO2002069955A1 Method and formula for anti-tumor and anti-matastatic effect |
| 09/12/2002 | WO2002069949A2 Combination therapy for reduction of toxycity of chemotherapeutic agents |
| 09/12/2002 | WO2002069945A2 Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors |
| 09/12/2002 | WO2002069944A2 Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists |
| 09/12/2002 | WO2002069942A1 Adhesive patch |
| 09/12/2002 | WO2002069941A1 Transdermal therapeutic system for the administration of partial dopamine-d2 agonists |
| 09/12/2002 | WO2002069940A2 Highly flexible transdermal therapeutic system having nicotine as active substance |
| 09/12/2002 | WO2002069939A2 Taste masked pharmaceutical compositions |
| 09/12/2002 | WO2002069938A1 Production of nanoparticles from methyl vinyl ether copolymer and maleic anhydride for the administration of hydrophilic pharmaceuticals, more particularly of puric and pyrimidinic bases |
| 09/12/2002 | WO2002069937A1 Compounds and compositions for delivering active agents |
| 09/12/2002 | WO2002069936A2 Pharmaceutical composition of ibuprofen |
| 09/12/2002 | WO2002069935A1 Fluid delivery device and associated method |
| 09/12/2002 | WO2002069934A1 Preparations quickly disintegrating in oral cavity |
| 09/12/2002 | WO2002069933A1 Tablets quickly disintegrating in oral cavity |
| 09/12/2002 | WO2002069932A1 Foaming compositions |
| 09/12/2002 | WO2002069931A1 Method for making water soluble a poorly water-soluble antiseptic |
| 09/12/2002 | WO2002069930A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | WO2002069929A1 Trifunctional systems for chronic illnesses |
| 09/12/2002 | WO2002069906A2 Compounds and methods for the treatment of urogenital disorders |
| 09/12/2002 | WO2002069897A2 Method and apparatus for compounding individualized dosage forms |
| 09/12/2002 | WO2002069888A2 Serotonin reuptake inhibitor formulations |
| 09/12/2002 | WO2002053197A3 Hot melt adhesives for dermal application |
| 09/12/2002 | WO2002050001A3 Non-halogenated naphthol compounds and antimicrobial compositions containing the same |
| 09/12/2002 | WO2002038131A3 Process |
| 09/12/2002 | WO2002022132A3 Novel topical oestroprogestational compositions with systemic effect |
| 09/12/2002 | WO2002017735A3 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate |
| 09/12/2002 | WO2002013784A3 Drug delivery system with bilayer electrodes |
| 09/12/2002 | WO2002002096A3 Oral compositions comprising host-response modulating agent |
| 09/12/2002 | WO2001097801A3 Dry powder formulation comprising racecadotril |
| 09/12/2002 | WO2001089558A3 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states |
| 09/12/2002 | WO2001089520A3 Dehydroascorbic acid formulations and uses thereof |
| 09/12/2002 | WO2001085218A3 Acylated cyclodextrin guest inclusion complexes |
| 09/12/2002 | WO2001047562A3 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 09/12/2002 | WO2001047497A3 Controlled release pharmaceutical composition containing tramadol hydrochloride |
| 09/12/2002 | WO2001041753A3 Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds |
| 09/12/2002 | WO2001034174A3 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 09/12/2002 | WO2001015700A9 POLYMORPHS OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-α]-PYRIMIDIN -7-YL }PHENYL )ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO |
| 09/12/2002 | WO2001013986A9 Delivery system for therapy comprising hollow seeds, preferably metal, and use thereof |
| 09/12/2002 | WO2001012210A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 09/12/2002 | WO2001011009A3 Intestinal gene therapy |
| 09/12/2002 | US20020129385 Medthods for improving long-term memory storage and retrieval |
| 09/12/2002 | US20020128599 Transdermal drug delivery devices having coated microprotrusions |